The U.S. Food and Drug Administration confirmed on Thursday that a meeting of its independent advisory panel to discuss the composition of this year's flu vaccine has been canceled and the regulator would instead make recommendations later.

Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health agencies under Robert F. Kennedy Jr.’s leadership.

The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza vaccines, raising concerns about the timeline for manufacturing next winter's flu shots.

It's the second such disruption to a federal vaccine advisory panel since Robert F. Kennedy Jr. became the nation’s top health official earlier this month.

WA U.S. Senator Patty Murray and others expressed grave concerns over the FDA's decision to cancel a critical meeting amid the worst flu season in 15 years.

The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.

It comes as RFK Jr., a vaccine skeptic who now leads the Department of Health and Human Services, makes moves that could affect vaccination uptake and policy.

The Vaccines and Related Biological Products Advisory Committee was supposed to meet on March 13 to recommend to the agency which flu strains should be included in influenza shots for the Northern Hemisphere’s next flu season.